Cardiac Biomarkers Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Cardiac Biomarkers Market size is expected to grow at an annual average of 7% during 2021-2027. Heart biomarkers are protein molecules that are released into the blood after heart damage or cardiac stress. These biomarkers serve as potential tools to detect a variety of cardiovascular diseases (CVDs), including cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome (ACS). Heart biomarker testing allows doctors to determine a patient’s risk associated with such a disease.

The following segmentation are covered in this report:

By Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute coronary syndrome (ACS)
• Atherosclerosis
• Other applications

BY BIOMARKERS TYPE

• Creatine kinase (CK-MB)
• Troponins
• Myoglobin
• Natriuretic peptides (BNP and NT-proBNP)
• Ischemia modified albumin (IMA)
• Other biomarkers type

Company Profile

• ABBOTT LABORATORIES
• BECTON, DICKINSON AND COMPANY
• BIOMERIEUX, INC.
• BIO-RAD LABORATORIES, INC.
• DANAHER CORPORATION
• F. HOFFMANN-LA ROCHE LTD.
• PERKINELMER INC.
• SIEMENS AG
• THERMO FISHER SCIENTIFIC, INC.
• TOSOH CORPORATION

Scope of the report

The research study analyses the Cardiac Biomarkers Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Cardiac Biomarkers Market Report

• What was the Cardiac Biomarkers Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Cardiac Biomarkers Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.